scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1028780052 |
P356 | DOI | 10.1007/S11894-999-0040-4 |
P8608 | Fatcat ID | release_gufyspmu6ndmlkic7uny3uqgle |
P698 | PubMed publication ID | 10980955 |
P2093 | author name string | Lloyd-Still JD | |
Beno DW | |||
Kimura RM | |||
P2860 | cites work | Colonic toxicity from pancreatins: a contemporary safety issue | Q33545562 |
Colonic strictures in children with cystic fibrosis | Q34328035 | ||
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis | Q34422620 | ||
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis | Q34494540 | ||
Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee | Q40368117 | ||
Fibrosing colonopathy in cystic fibrosis: results of a case-control study | Q40369145 | ||
Crohn's disease and cystic fibrosis | Q40736073 | ||
Fibrosing colonopathy in children with cystic fibrosis. | Q41357422 | ||
The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature | Q41432518 | ||
Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States | Q45123631 | ||
Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. | Q50911753 | ||
Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes | Q61912464 | ||
Diffuse fibrosis of the colon complicating cystic fibrosis | Q71106493 | ||
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements | Q71520306 | ||
Neuropathy and vasculopathy in colonic strictures from children with cystic fibrosis | Q71542644 | ||
Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis | Q71680964 | ||
Comparative and experimental pathology of fibrosing colonopathy | Q71681090 | ||
Cystic fibrosis and colonic strictures. A new "iatrogenic" disease | Q71746278 | ||
Cystic fibrosis-associated colitis and fibrosing colonopathy | Q71749751 | ||
Colonopathy in a noncystic fibrosis patient: from excess pancreatic enzymes | Q71950917 | ||
High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better" | Q72153423 | ||
Histological changes in mouse colon after single- and split-dose irradiation | Q72627350 | ||
Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes | Q72676736 | ||
Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy | Q72730408 | ||
Ultrasound studies of the intestinal wall in patients with cystic fibrosis | Q73669847 | ||
The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat | Q74545612 | ||
Distribution of acute bowel inflammation determined by technetium-labeled white blood cells in children with inflammatory bowel disease | Q74554673 | ||
Indomethacin and pancreatic enzymes synergistically damage intestine of rats | Q77470629 | ||
P433 | issue | 3 | |
P921 | main subject | cystic fibrosis | Q178194 |
P304 | page(s) | 231-237 | |
P577 | publication date | 1999-06-01 | |
P1433 | published in | Current gastroenterology reports | Q26842032 |
P1476 | title | Cystic fibrosis colonopathy | |
P478 | volume | 1 |
Q35814231 | Evidence for a Cystic Fibrosis Enteropathy |
Q36184845 | Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency |
Q41817145 | Successful non-invasive treatment of stricturing fibrosing colonopathy in an adult patient |
Q35585390 | The multifaceted role of radiology in small bowel obstruction |
Q40564391 | Treatment of Gastrointestinal Problems in Cystic Fibrosis |
Q36685523 | Wound healing and fibrosis in intestinal disease |
Search more.